发明公开
EP1303278A1 KOMBINATION EINES TRANSDERMALEN THERAPEUTISCHEN SYSTEMS UND EINER ORALEN UND/ODER PARENTERALEN ZUBEREITUNG ENTHALTEND DOPAMINAGONISTEN ZUR BEHANDLUNG DOPAMINERGER ERKRANKUNGEN 有权
的透皮治疗系统组合以及用于治疗多巴胺能疾病的口服和/或肠胃制备含多巴胺激动剂

  • 专利标题: KOMBINATION EINES TRANSDERMALEN THERAPEUTISCHEN SYSTEMS UND EINER ORALEN UND/ODER PARENTERALEN ZUBEREITUNG ENTHALTEND DOPAMINAGONISTEN ZUR BEHANDLUNG DOPAMINERGER ERKRANKUNGEN
  • 专利标题(英): Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
  • 专利标题(中): 的透皮治疗系统组合以及用于治疗多巴胺能疾病的口服和/或肠胃制备含多巴胺激动剂
  • 申请号: EP01976150.1
    申请日: 2001-08-24
  • 公开(公告)号: EP1303278A1
    公开(公告)日: 2003-04-23
  • 发明人: HOROWSKI, ReinhardTACK, Johannes
  • 申请人: NeuroBiotec GmbH
  • 申请人地址: Chausseestrasse 94 10115 Berlin DE
  • 专利权人: NeuroBiotec GmbH
  • 当前专利权人: NeuroBiotec GmbH
  • 当前专利权人地址: Chausseestrasse 94 10115 Berlin DE
  • 代理机构: Wablat, Wolfgang, Dr.Dr.
  • 优先权: DE10053397 20001020
  • 国际公布: WO02034267 20020502
  • 主分类号: A61K31/48
  • IPC分类号: A61K31/48 A61P25/14 A61P25/16 A61K31/45 A61K31/13 A61K9/00 A61K9/20 A61K9/70
KOMBINATION EINES TRANSDERMALEN THERAPEUTISCHEN SYSTEMS UND EINER ORALEN UND/ODER PARENTERALEN ZUBEREITUNG ENTHALTEND DOPAMINAGONISTEN ZUR BEHANDLUNG DOPAMINERGER ERKRANKUNGEN
摘要:
The invention relates to the use of a dopamine agonist in the form of an agent, comprising at least two physically separate compositions, of which one is a transdermal therapeutic system (TTS), containing the dopaminergic agent and one or several other compositions containing the same dopaminergic agent and suitable for oral and/or parenteral administration. Said compositions are suitable for the individually dosed and controlled treatment of dopaminergically treatable diseases with the following elements: a) the TTS is continuously applied, b) within the duration of application in a) the composition for oral or parenteral dosage is administered.
信息查询
0/0